This page describes pharmacological agents that may have legal restrictions, side effects, and drug interactions in your jurisdiction. Information is for educational research only — consult a clinician before considering any compound.
Lutein
Xanthophyll carotenoid concentrated in retinal macula + cerebral cortex.
Aliases (11)
Overview
What is Lutein?
Xanthophyll carotenoid concentrated in retinal macula + cerebral cortex. AREDS2-protocol dose is 10 mg lutein + 2 mg zeaxanthin daily with a fat-containing meal — three months to plateau on MPOD, six months to plateau on visual performance gains. Strong evidence for retinal protection in older AMD-risk populations (AREDS2 + 10-yr follow-up); reasonable young-adult evidence for contrast sensitivity, glare recovery, photostress recovery, and visual fatigue in screen-heavy users (Stringham 2017, Lopresti 2025). Safety is excellent — only side effect is reversible carotenodermia at >20 mg/day chronic intake. For Dylan: OPTIONAL-ADD. Computer work + MMA visual demands make a case, but dietary lutein (2 cups leafy greens + 2 egg yolks daily) saturates serum response — supplement only if diet falters during cutting phases or training camps where greens consistency drops. Skip if smoking history is the only flag (lutein is safe in smokers — unlike beta-carotene). FloraGLO free-form lutein is the gold-standard ingredient brand; marigold-flower-derived. ~$8-12/month.
Research Indications
Macula lutea
Lutein + zeaxanthin + meso-zeaxanthin accumulate in Henle's fiber layer surrounding the foveola at ~1,000× the concentration of any other…
Cerebral cortex
Frontal and occipital cortex specifically — emerging evidence ties cortical lutein concentration to cognitive performance independent of …
Skin
Modest accumulation; contributes to photoprotection at high intakes.
Adipose
Storage depot.
Peptide Interactions
AREDS2 protocol = 10 mg L + 2 mg Z (5:1 ratio, the natural ratio in retinal macular pigment). Lutein dominates parafoveal macula; zeaxanthin dominates fovea.…
Some formulations add 0.5-2 mg meso-zeaxanthin. Meso-zeaxanthin is endogenously formed in the retina from lutein via RPE65 isomerization, but supplemental me…
DHA is the major lipid in photoreceptor outer-segment membranes. Lutein partitions into these same membranes. AREDS2 sub-analyses showed an interaction (L+Z …
Regenerates oxidized carotenoid radicals and shares lipoprotein transport. Mild kinetic synergy.
Recycles oxidized vitamin E, indirectly supporting the carotenoid recycling pathway. Already V4-locked.
Original AREDS formula component. RPE concentrates zinc and uses it as antioxidant cofactor. Modest direct synergy with L+Z protection of retinal tissue.
Different carotenoid class (ketocarotenoid) — partitions into both leaflets of the bilayer where lutein has a surface preference. Some evidence (Senju 2023) …
Tripled to quadrupled absorption. Not a "stack" per se but co-ingestion with fat is non-negotiable for full bioavailability.
Competes at intestinal SR-BI/CD36 carotenoid uptake transporters. High-dose beta-carotene can reduce serum lutein by 30-40%. Plus the former-smoker lung canc…
Bile-acid sequestrants and fat-blockers reduce carotenoid absorption.
Functional zero absorption.
What to Expect
- Week 1Tolerability and dose-response.
- Week 2-4Early effect window.
- Week 4-8Peak benefit assessment.
- Week 8+Cycle decision point.
Side Effects & Safety 3
Side Effects
- 1Carotenodermia (yellowing of palms, soles, and to a lesser extent face) at high chronic doses (>20 mg/day for several months). Harmless, reversible on dose reduction or discontinuation. Distinct from jaundice — sclerae are spared, not pathologic. More common in lighter-skinned individuals where the contrast is visible.
- 2Mild GI upset if taken on empty stomach (rare, mitigated by fat co-ingestion).
- 3Aesthetic carotenoid-driven skin tint that may be desirable or undesirable depending on user preference — research-grade users sometimes report a subtle "warmer skin tone" within 8-12 weeks.
When to Stop
- Crystalline lutein maculopathy — exceptional cases at extremely high chronic intakes (>20 mg/day for multi-year duration combined with high-fat diet). Reversible on discontinuation. Functionally not a concern at AREDS2 doses.
- No documented serious adverse events at supplementation doses in the 4,203-participant AREDS2 trial over 5 years and 10-year follow-up. Long-term safety is among the best-characterized in the entire supplement universe.
- CARET trial (1996): 30 mg beta-carotene + 25,000 IU retinyl palmitate in smokers/asbestos workers — STOPPED EARLY due to 28% increase in lung cancer incidence.
- ATBC trial (1994): 20 mg beta-carotene in male smokers — 18% increase in lung cancer.
- AREDS2 10-year follow-up (2022): Beta-carotene OR 1.82 for lung cancer in former smokers; lutein/zeaxanthin OR 1.15 (ns) — no excess risk.
References
Chew EY et al. 2013 — AREDS2 trial primary report (JAMA, PMID 23644932)
pivotal 5-year RCT, n=4,203, lutein/zeaxanthin replaced beta-carotene in revised AREDS formulation.
View StudyChew EY et al. 2022 — AREDS2 Report 28, 10-year follow-up (JAMA Ophthalmology, PMID 35653117)
definitive long-term safety + efficacy data; beta-carotene lung cancer signal in former smokers; lutein/zeaxanthin reassuring.
View StudyStringham JM et al. 2017 — Macular carotenoid supplementation in high screen-time users (Foods, PMID 28661438)
6-month RCT, 48 young adults ≥6 hr/day screens; improved MPOD, visual performance, eye strain, headache, sleep quality.
View StudyRenzi-Hammond LM et al. 2017 — L+Z in young healthy adults cognitive function (Nutrients, PMID 29135938)
12-month RCT, n=51, increased spatial memory at AREDS2 dose.
View StudyHammond BR et al. 2017 — L/Z in older adults cognitive function (Frontiers Aging Neurosci, PMID 28824416)
1-year RCT, improved complex attention + cognitive flexibility.
View StudyLindbergh CA et al. 2018 — L+Z fMRI cerebral perfusion in older adults (J Int Neuropsychol Soc, PMID 28695791)
Cohen's d=0.84 buffering of verbal learning decline; perfusion mechanism.
View StudyMewborn CM et al. 2019 — L+Z brain morphology preservation (Nutrients, PMID 31871787)
gray matter structural integrity over 1 year.
View StudyHammond BR & Wooten BR 2012 — Macular carotenoid filtering of blue haze (Vision Research, PMID 22588116)
theoretical + empirical basis for contrast sensitivity gain.
View StudyBovier ER & Hammond BR 2015 — L+Z visual processing speed in young adults (Arch Biochem Biophys, PMID 25483230)
~12% CFF improvement, ~10% visual motor RT improvement.
View StudyParekh R et al. 2024 — L+Z in children visual + cognitive (Adv Ther, PMID 38363462)
180-day RCT, 60 children, improved MPOD + focus + memory + processing speed.
View StudyLopresti AL & Smith SJ 2025 — Lute-gen on dry eye + photostress in screen users (Frontiers in Nutrition)
6-month RCT; objective tear-test + photostress gains; subjective gain confounded by placebo response.
View StudyMarigold lutein bioavailability — free vs ester form (PMID 38794653)
RCT confirming free-form (FloraGLO-style) lutein has higher serum response per mg than ester form.
View StudyLinus Pauling Institute carotenoids monograph
comprehensive review reference.
View StudyKemin FloraGLO ingredient science whitepaper
ingredient-brand reference; GRAS status, dosing rationale.
View StudyCARET trial follow-up (NEJM 1996)
beta-carotene + retinol lung cancer signal in smokers; comparator to lutein safety profile.
View StudyATBC Cancer Prevention Study
alpha-tocopherol + beta-carotene male smokers; 18% increase in lung cancer with beta-carotene arm.
View StudyLatest research
- rctLutein/zeaxanthin (Lute-gen) on eye health, eye strain, sleep, and attention in high-screen users — RCT6-month RCT, 10 mg L + 2 mg Z in high-screen users (>6 hr/day) improved Schirmer tear test, tear film break-up time, photostress recovery vs placebo. Objective gains exceeded subjective gains (placebo response strong on self-report).
- rctBioavailability of lutein from marigold flowers — free vs. ester forms RCTCrossover RCT comparing free-form (FloraGLO-style) vs. ester-form lutein. Free form yielded higher serum response per mg ingested; both forms improved visual contrast threshold. Practical implication: free-form lutein supplements (FloraGLO) deliver more bioavailable lutein per labeled mg than ester forms (Xangold).
- rctLutein and zeaxanthin in children: dynamic visual + cognitive performance RCT180-day RCT, 60 children, 10 mg L + 2 mg Z gummies improved MPOD, serum L/Z, eye strain, focus, memory, processing speed vs placebo. Signal emerged at day 42, sustained to day 180. No safety concerns.
How was your experience with this compound?
Anonymous · one vote per session · results below at 5+ votes.
See something off?
Most of this wiki is AI-generated. Suggest a correction, dosing update, or new evidence — we review every submission.